Previous 10 | Next 10 |
home / stock / rxrx / rxrx articles
NVIDIA Corporation (NASDAQ: NVDA) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 21, 2024. Analysts...
Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading higher after Nvidia Corp (NASDAQ:NVDA), in its 13F filing, disclosed ...
Nvidia Corp (NASDAQ:NVDA), a leading force in the artificial intelligence (AI) industry, recently revealed its investment portfolio, showcasin...
On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling a substantial portion of its stake in DraftKings Inc (NASDAQ:DKNG). T...
ecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) shares are trading higher Tuesday and the stock is up more than 80% over past month. The stock is amo...
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Acuity Brands, Inc. (NYSE: AYI) rose sharply Tuesd...
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) r...
On Tuesday, Cathie Wood-led Ark Invest made a significant purchase of Roku Inc (NASDAQ:ROKU) shares. This decision comes amidst a period of market ...
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Wednesday. Shares of Hewlett Packard Enterprise Company (NYSE: HP...
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...